Clinical outcome in chordoma: Utility of flow cytometry in DNA determination

Spine

Volumn 27, Issue 4, 2002, Pages 374-379

  Berven, Sigurd ^a,d   Zurakowski, David ^b   Mankin, Henry J ^a,c   Gebhardt, Mark C ^a,c   Springfield, Dempsey S ^a,c   Hornicek, Francis J ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chordoma; DNA; Flow cytometry; Local recurrence; Outcome; Survival

Indexed keywords

PROPIDIUM IODIDE;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CHORDOMA; DIPLOIDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOGRAM; HUMAN; KAPLAN MEIER METHOD; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SACRUM; SPINE TUMOR; TUMOR RECURRENCE;

ADULT; AGED; CELL CYCLE; CHORDOMA; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037082571     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200202150-00010     Document Type: Article

References (58)

1. Chordoma: Role of radiation therapy
2. Chordoma: Natural history and treatment results in 33 cases
3. Cellular DNA content as a marker of neoplasia in man
4. Chordoma of the mobile spine: A clinicopathologic analysis of 40 patients
5. Chordoma of the spine above the sacrum: Treatment outcome in 21 cases
6. Differential pattern of DNA-aneuploidy in human malignancies
7. Cytogenetic investigation of chordomas of the skull
8. Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas
9. Chordoma: A clinicopathologic study of metastasis
10. Regression models and life-tables
11. Chordoma: A study of 59 cases
12. Cytogenetics of sacral chordoma
13. Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor
14. Lesions of uncertain origin originating in bone
15. Dedifferentiated chordoma: Response to aggressive chemotherapy in two cases
16. Chromosomal abnormalities in two chordomas
17. Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression and flow cytometric analysis: Prognostic significance in acute nonlymphoblastic leukemia
18. Malignant fibrous histiocytoma developing in irradiated sacral chordoma
19. Flow cytometry using paraffin-embedded tissue: Five years on
20. Tumor heterogeneity in osteosarcoma as identified by flow cytometry
21. Chordomas with malignant spindle cell components: A DNA flow cytometric and immunohistochemical study with histogenetic implications
22. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
23. Clinicopathotogical study of sacrococcygeal chordoma
24. An evaluation of the diagnosis and treatment of chordoma
25. Nonparametric estimation from incomplete ohservations
26. Flow and image cytometric DNA analysis in Ewing's sarcoma
27. Prognostic factors in chondrosarcoma: A comparative study of cellular DNA content and clinicopathologic features
28. Flow DNA analysis of primary bone tumors: Relationship between cellular DNA content and histolopathologic classification
29. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to chemotherapy. A Southwest Oncology Group study
30. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma
31. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
32. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity
33. Grading of bone tumors by analysis of nuclear DNA content using flow cytometry
34. Flow cytometric studies of human osteosarcoma
35. "Dedifferentiated" chordoma: A clinicopathologic and immunohistochemical study of three cases
36. Clonal chromosome aberrations in three sacral chordomas
37. Chordoma
38. Benign and malignant tumors of the sacrum
39. Proliferative activities in conventional chordoma: A clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing diffuse proliferation and nuclear atypia
40. Salvage of the limb in the treatment of malignant pelvic tumors
41. Cytogenetic analysis of two sacral chordomas
42. Demonstration of cytokeratins and an epithelial membrane antigen in chordomas and human fetal notochord
43. Operative treatment of sacrococcygeal chordoma: A review of twenty-one cases
44. Molecular pathology of soft tissue and bone tumors: A review
45. High amputation of the sacrum for extirpation of tumors: Principles and technique
46. Complete removal of vertebrae for extirpation of tumors: A 20-year experience
47. Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine
48. Spinal chordomas
49. Chordomas
50. Chordomas
51. Chordoma: Evaluation of clinical behavior and treatment modalities
52. Total sacrectomy and reconstruction for huge sacral tumors
53. Total en bloc spondylectomy: A new surgical technique for primary malignant vertebral tumors
54. Flow cytometry: Principles and applications. I
55. A clinicopathologic review of 25 cases of chordoma (a pleomorphic and metastasizing neoplasm)
56. DNA index: Parameter for the prediction of prognosis and primary radioresistance?
57. The cellular biology of bone tumors